SCHEMBL13487476

SCHEMBL13487476

Cc1ccc2c(-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)c3ccccc3c(-c3ccc4c(c3)-c3ccccc3C4(C)C)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.39
MAPT P10636 9/20 0.39
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
HPGD P15428 7/20 0.39
KDM4E B2RXH2 6/20 0.37
LMNA P02545 4/20 0.37
NPSR1 Q6W5P4 4/20 0.37
RECQL P46063 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HSP90AA1 P07900 1/20 0.37
NTSR1 P30989 1/20 0.36
THRB P10828 1/20 0.36
GLA P06280 1/20 0.35
AGTR1 P30556 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487853 0.95 ALDH1A1 (0.38) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487550 0.92 MEN1 (0.40) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487765 0.91 MEN1 (0.39) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487474 0.90 MEN1 (0.40) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487477 0.90 MEN1 (0.35) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487635 0.88 MEN1 (0.37) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487715 0.88 CYP1A1 (0.38) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487453 0.88 ALDH1A1 (0.42) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13488162 0.87 MEN1 (0.39) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL13487064 0.86 ALDH1A1 (0.38) ALDH1A1MAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALDH1A1 101/4885MAPT 2219/4885MEN1 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.